5120 POSTER Is Extracapsular Tumour Spread a Prognostic Factor in Patients With Early Breast Cancer?

There was no significant difference in age (p = 0.917), educational level (p = 0.851), or BMI (p = 0.255) between CAM users and non-users. CAM users and non-users showed no significant difference in trust in conventional treatment (p = 0.374) or quality of life (p = 0.501). There was no significant difference in health specific locus of control. Vitamins and minerals were the most common (35.2%) used natural CAM product. Conclusion: CAM use is common among recently diagnosed breast cancer patients in the Netherlands. Physicians and other health care providers should increase their knowledge about CAM therapies. CAM should be discussed with patients, since CAM may cause clinically significant drug interactions.